Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
23 "Gou Young Kim"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
WITHDRAWN:A Clinicopathologic Study of 220 Cases of Pulmonary Sclerosing Pneumocytoma in Korea: A Nationwide Survey
Myunghee Kang, Seung Yeon Ha, Joung Ho Han, Mee Sook Roh, Se Jin Jang, Hee Jin Lee, Heae Surng Park, Geon Kook Lee, Kyo Young Lee, Jin-Haeng Chung, Yoo Duk Choi, Chang Hun Lee, Lucia Kim, Myoung Ja Chung, Soon Hee Jung, Gou Young Kim, Wan-Seop Kim
Received April 4, 2018  Accepted July 9, 2018  Published online July 16, 2018  
DOI: https://doi.org/10.4132/jptm.2018.07.10    [Accepted]
  • 4,870 View
  • 63 Download
Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24
Hyuck Cho, Sung-Jig Lim, Kyu Yeoun Won, Go Eun Bae, Gou Young Kim, Ji Won Min, Byeong-joo Noh
J Pathol Transl Med. 2016;50(1):45-51.   Published online December 14, 2015
DOI: https://doi.org/10.4132/jptm.2015.10.16
  • 9,097 View
  • 121 Download
  • 39 Web of Science
  • 39 Crossref
AbstractAbstract PDF
Background
A decrease in the number of tissue eosinophils is known to reflect the malignancy potential of neoplastic lesions and even prognosis. Increased levels of the chemokines CCL11 and CCL24 in serum and tissue are also known to have diagnostic value as serum tumor markers or prognostic factors. The aim of this study was to evaluate the correlation between the degree of tissue eosinophilia and the expression of these chemokines in the glandular and stromal cells of colorectal neoplastic lesions ranging from benign to malignant tumors. Methods: We counted the number of infiltrating eosinophils in neoplastic lesion tissue and we evaluated the expression of CCL11 and CCL24 in glandular cells and stromal cells by immunohistochemical staining. Results: The results showed that the number of eosinophils decreased significantly and the expression of CCL11 and CCL24 in glandular cells decreased with tumor progression, whereas the stromal expression of CCL11 and CCL24 appeared to increase. Conclusions: The discrepancy in CCL11 and CCL24 expression between glandular cells and stromal cells might shed light on how colorectal cancer evades the immune system, which would enable further development of immunotherapies that target these chemokines. Further research on eosinophil biology and the expression pattern of chemokines in tumor cells is needed.

Citations

Citations to this article as recorded by  
  • Genetic fusion of CCL11 to antigens enhances antigenicity in nucleic acid vaccines and eradicates tumor mass through optimizing T-cell response
    Hailong Qi, Zhongjie Sun, Tianle Gao, Yanling Yao, Yu Wang, Weiwei Li, Xudong Wang, Xiaofang Wang, Defang Liu, Jian-Dong Jiang
    Molecular Cancer.2024;[Epub]     CrossRef
  • Eosinophilia in cancer and its regulation by sex hormones
    Sandeep Artham, Ching-Yi Chang, Donald P. McDonnell
    Trends in Endocrinology & Metabolism.2023; 34(1): 5.     CrossRef
  • A novel inflammation-related signature for predicting prognosis and characterizing the tumor microenvironment in colorectal cancer
    Jinna Li, Jiapeng Yang, Rui Xing, Ying Wang
    Aging.2023; 15(7): 2554.     CrossRef
  • Potential Mechanisms of Melatonin in Osteosarcoma and Bone-Related Neoplasms: Updated Review
    Parisa Maleki Dana, Fatemeh Sadoughi, Russel J. Reiter, Bahman Yousefi, Zatollah Asemi
    Mini-Reviews in Medicinal Chemistry.2023; 23(3): 290.     CrossRef
  • Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies (C3Mab-6 and C3Mab-7)
    Nami Tateyama, Teizo Asano, Tomohiro Tanaka, Yu Isoda, Yuki Okada, Hiyori Kobayashi, Guanjie Li, Ren Nanamiya, Takeo Yoshikawa, Mika K. Kaneko, Hiroyuki Suzuki, Yukinari Kato
    Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.2023; 42(2): 68.     CrossRef
  • Improved colorectal cancer screening by adding noninvasive serum-based biomarkers
    Ayman M. Farouk, Mona K. ElDeeb, Mona H. Kandil, Noha A. ElBanna, Mohamed M. Shamseya, Amel S. Elsedafy, Nevine L. Micheal, Mohamed A. Selimah
    The Egyptian Journal of Surgery.2023; 42(1): 1.     CrossRef
  • Eosinophils in the tumor microenvironment: implications for cancer immunotherapy
    Sasan Ghaffari, Nima Rezaei
    Journal of Translational Medicine.2023;[Epub]     CrossRef
  • A Novel Gene Signature Associated with Protein Post-translational Modification to Predict Clinical Outcomes and Therapeutic Responses of Colorectal Cancer
    Jun Liu, Peng Zhu
    Molecular Biotechnology.2023;[Epub]     CrossRef
  • Assessing serum cytokine profiles in inflammatory breast cancer patients using Luminex® technology
    Maryem Bessaad, Azza Habel, Mariem Hadj Ahmed, Weili Xu, Mouna Stayoussef, Hanen Bouaziz, Monia Hachiche, Amel Mezlini, Anis Larbi, Besma Yaacoubi-Loueslati
    Cytokine.2023; 172: 156409.     CrossRef
  • Systemic Evaluation of the Effect of Diabetes Mellitus on Breast Cancer in a Mouse Model
    Nana Wei, Jinmiao Lu, Zhibing Lin, Xiaoyu Wang, Mengmeng Cai, Shengyao Jiang, Xiaoyu Chen, Shilan Zhu, Dong Zhang, Li Cui
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies
    Medina Mamtimin, Akif Pinarci, Chao Han, Attila Braun, Hans-Joachim Anders, Thomas Gudermann, Elmina Mammadova-Bach
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Immune-Related Biomarkers Associated with Lung Metastasis from the Colorectal Cancer Microenvironment
    Wang Da, Wu Yinhang, Zhuang Jing, Xu Jiamin, Gao Xinyi, Song Yongmao, Pan Yuefen
    Journal of Interferon & Cytokine Research.2022; 42(5): 220.     CrossRef
  • Cancer-Associated Fibroblasts Promote Tumor Aggressiveness in Head and Neck Cancer through Chemokine Ligand 11 and C-C Motif Chemokine Receptor 3 Signaling Circuit
    Wen-Yen Huang, Yaoh-Shiang Lin, Yu-Chun Lin, Shin Nieh, Yi-Ming Chang, Tsai-Yu Lee, Su-Feng Chen, Kuender D. Yang
    Cancers.2022; 14(13): 3141.     CrossRef
  • Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth
    Rachel A. Cederberg, Sarah Elizabeth Franks, Brennan J. Wadsworth, Alvina So, Lisa R. Decotret, Michael G. Hall, Rocky Shi, Michael R. Hughes, Kelly M. McNagny, Kevin L. Bennewith
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis
    Qing Lai, Haifei Feng, Shuli Yang
    Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
  • Epitope Mapping of Anti-Mouse CCR3 Monoclonal Antibodies Using Flow Cytometry
    Nami Tateyama, Teizo Asano, Hiroyuki Suzuki, Guanjie Li, Takeo Yoshikawa, Tomohiro Tanaka, Mika K. Kaneko, Yukinari Kato
    Antibodies.2022; 11(4): 75.     CrossRef
  • Granulocytes and Cells of Granulocyte Origin—The Relevant Players in Colorectal Cancer
    Izabela Siemińska, Ewa Poljańska, Jarek Baran
    International Journal of Molecular Sciences.2021; 22(7): 3801.     CrossRef
  • CCL24 Protects Renal Function by Controlling Inflammation in Podocytes
    Youdi Wang, Xue Wu, Mengya Geng, Jiamin Ding, Kangjia Lv, Hui Du, Jiahui Ding, Wenjun Pei, Xin Hu, Jing Gu, Lizhuo Wang, Yao Zhang, Jialin Gao, Roberta Rizzo
    Disease Markers.2021; 2021: 1.     CrossRef
  • Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associations
    Sharon Grisaru-Tal, Michal Itan, Daniel G Grass, Javier Torres-Roca, Steven A Eschrich, Yaara Gordon, Avishay Dolitzky, Inbal Hazut, Shmuel Avlas, Elizabeth A Jacobsen, Tomer Ziv-Baran, Ariel Munitz
    OncoImmunology.2021;[Epub]     CrossRef
  • Discovery of core gene families associated with liver metastasis in colorectal cancer and regulatory roles in tumor cell immune infiltration
    Wei-Qing Liu, Wen-Liang Li, Shu-Min Ma, Lei Liang, Zhi-Yong Kou, Jun Yang
    Translational Oncology.2021; 14(3): 101011.     CrossRef
  • Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity
    Sharon Grisaru-Tal, Shai Dulberg, Lir Beck, Chunyan Zhang, Michal Itan, Soroor Hediyeh-zadeh, Julie Caldwell, Perri Rozenberg, Avishay Dolitzky, Shmuel Avlas, Inbal Hazut, Yaara Gordon, Ophir Shani, Shlomo Tsuriel, Motti Gerlic, Neta Erez, Nicolas Jacquel
    Cancer Research.2021; 81(21): 5555.     CrossRef
  • Tumor Immunology and Tumor Evolution: Intertwined Histories
    Jérôme Galon, Daniela Bruni
    Immunity.2020; 52(1): 55.     CrossRef
  • A new dawn for eosinophils in the tumour microenvironment
    Sharon Grisaru-Tal, Michal Itan, Amy D. Klion, Ariel Munitz
    Nature Reviews Cancer.2020; 20(10): 594.     CrossRef
  • Eotaxins and Their Receptor in Colorectal Cancer—A Literature Review
    Monika Zajkowska, Barbara Mroczko
    Cancers.2020; 12(6): 1383.     CrossRef
  • Eosinophilic peritonitis with colon cancer: a case report
    Ryo Ataka, Hirokazu Tanaka, Shintaro Yagi, Kei Yamane, Kenji Yoshino, Tomoyuki Miyauchi, Tomoaki Yoh, Keiichi Arafuka, Shinichi Fujita, Akihiko Hamada, Bunji Endo, Shinji Uemoto
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor–A Literature Review
    Jan Korbecki, Klaudyna Kojder, Katarzyna Barczak, Donata Simińska, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska-Bosiacka
    International Journal of Molecular Sciences.2020; 21(16): 5647.     CrossRef
  • CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
    Jan Korbecki, Klaudyna Kojder, Donata Simińska, Romuald Bohatyrewicz, Izabela Gutowska, Dariusz Chlubek, Irena Baranowska-Bosiacka
    International Journal of Molecular Sciences.2020; 21(21): 8412.     CrossRef
  • Opposing roles of eosinophils in cancer
    Sonja C. S. Simon, Jochen Utikal, Viktor Umansky
    Cancer Immunology, Immunotherapy.2019; 68(5): 823.     CrossRef
  • Prognostic significance of inflammatory cell response in patients with colorectal cancer
    Katarzyna Jakubowska, Mariusz Koda, Wojciech Kisielewski, Luiza Kańczuga‑Koda, Waldemar Famulski
    Oncology Letters.2019;[Epub]     CrossRef
  • Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer
    Hadar Reichman, Michal Itan, Perri Rozenberg, Tal Yarmolovski, Eli Brazowski, Chen Varol, Nathan Gluck, Shiran Shapira, Nadir Arber, Udi Qimron, Danielle Karo-Atar, James J. Lee, Ariel Munitz
    Cancer Immunology Research.2019; 7(3): 388.     CrossRef
  • Developmental endothelial locus‐1 (Del‐1) antagonizes Interleukin‐17‐mediated allergic asthma
    Shu Yan, Li Chen, Qi Zhao, Ya‐Nan Liu, Rui Hou, Jing Yu, Hong Zhang
    Immunology & Cell Biology.2018; 96(5): 526.     CrossRef
  • Expression of Galectins-1 and Galectin-3 in Stomach and Colorectal Cancer with Tissue Eosinophilia
    Yu. V. Kolobovnikova, A. I. Dmitrieva, K. I. Yankovich, O. A. Vasil’eva, I. L. Purlik, V. S. Poletika, V. V. Novitskii, O. I. Urazova
    Bulletin of Experimental Biology and Medicine.2018; 165(2): 256.     CrossRef
  • The expression of CCL11/eotaxin, CCR3 receptor and eosinophil peroxidase in tumor tissue in gastric and colon cancers
    Yu. V. Kolobovnikova, K. I. Yankovich, E. V. Romanova, A. I. Dmitrieva, V. V. Novitskiy, O. I. Urazova
    Bulletin of Siberian Medicine.2018; 17(3): 80.     CrossRef
  • Friend or foe?
    Tommaso Colangelo, Giovanna Polcaro, Livio Muccillo, Giovanna D'Agostino, Valeria Rosato, Pamela Ziccardi, Angelo Lupo, Gianluigi Mazzoccoli, Lina Sabatino, Vittorio Colantuoni
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2017; 1867(1): 1.     CrossRef
  • CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis
    Lei Jin, Wei-Ren Liu, Meng-Xin Tian, Xi-Fei Jiang, Han Wang, Pei-Yun Zhou, Zhen-Bin Ding, Yuan-Fei Peng, Zhi Dai, Shuang-Jian Qiu, Jian Zhou, Jia Fan, Ying-Hong Shi
    Oncotarget.2017; 8(3): 5135.     CrossRef
  • Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer
    Susanne Blank, Henrik Nienhüser, Lena Dreikhausen, Leila Sisic, Ulrike Heger, Katja Ott, Thomas Schmidt
    Oncotarget.2017; 8(29): 47518.     CrossRef
  • The formation mechanisms of tumor-associated tissue eosinophilia in gastric cancer and colon cancer
    В.В. Новицкий, К.И. Янкович, Ю.В. Колобовникова, А.И. Дмитриева, О.И. Уразова, И.Л. Пурлик, Л.А. Кудяков, С.П. Чумакова
    ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia».2017; (4(61)): 74.     CrossRef
  • LncRNAs expression in adjuvant-induced arthritis rats reveals the potential role of LncRNAs contributing to rheumatoid arthritis pathogenesis
    Hui Jiang, Xiu-Juan Qin, Wei-Ping Li, Rong Ma, Ting Wang, Zhu-Qing Li
    Gene.2016; 593(1): 131.     CrossRef
  • Emerging Roles for Eosinophils in the Tumor Microenvironment
    Hadar Reichman, Danielle Karo-Atar, Ariel Munitz
    Trends in Cancer.2016; 2(11): 664.     CrossRef
Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey
Sang Hwa Lee, Wan Seop Kim, Yoo Duk Choi, Jeong Wook Seo, Joung Ho Han, Mi Jin Kim, Lucia Kim, Geon Kook Lee, Chang Hun Lee, Mee Hye Oh, Gou Young Kim, Sun Hee Sung, Kyo Young Lee, Sun Hee Chang, Mee Sook Rho, Han Kyeom Kim, Soon Hee Jung, Se Jin Jang, The Cardiopulmonary Pathology Study Group of Korean Society of Pathologists
J Pathol Transl Med. 2015;49(6):481-488.   Published online October 13, 2015
DOI: https://doi.org/10.4132/jptm.2015.09.14
  • 10,300 View
  • 94 Download
  • 19 Web of Science
  • 21 Crossref
AbstractAbstract PDF
Background
Analysis of mutations in the epidermal growth factor receptor gene (EGFR) is important for predicting response to EGFR tyrosine kinase inhibitors. The overall rate of EGFR mutations in Korean patients is variable. To obtain comprehensive data on the status of EGFR mutations in Korean patients with lung cancer, the Cardiopulmonary Pathology Study Group of the Korean Society of Pathologists initiated a nationwide survey. Methods: We obtained 1,753 reports on EGFR mutations in patients with lung cancer from 15 hospitals between January and December 2009. We compared EGFR mutations with patient age, sex, history of smoking, histologic diagnosis, specimen type, procurement site, tumor cell dissection, and laboratory status. Results: The overall EGFR mutation rate was 34.3% in patients with non-small cell lung cancer (NSCLC) and 43.3% in patients with adenocarcinoma. EGFR mutation rate was significantly higher in women, never smokers, patients with adenocarcinoma, and patients who had undergone excisional biopsy. EGFR mutation rates did not differ with respect to patient age or procurement site among patients with NSCLC. Conclusions: EGFR mutation rates and statuses were similar to those in published data from other East Asian countries.

Citations

Citations to this article as recorded by  
  • The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia
    Noni Novisari Soeroso, Fannie Rizki Ananda, Johan Samuel Sitanggang, Noverita Sprinse Vinolina
    F1000Research.2023; 11: 853.     CrossRef
  • Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients
    Changlong He, Chengcheng Wei, Jun Wen, Shi Chen, Ling Chen, Yue Wu, Yifan Shen, Huili Bai, Yangli Zhang, Xueping Chen, Xiaosong Li
    Journal of Cancer Research and Clinical Oncology.2022; 148(2): 321.     CrossRef
  • Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China
    Jun-Ling Wang, Yu-Dong Fu, Yan-Hong Gao, Xiu-Ping Li, Qian Xiong, Rui Li, Bo Hou, Ruo-Shan Huang, Jun-Feng Wang, Jian-Kun Zhang, Jia-Ling Lv, Chao Zhang, Hong-Wei Li
    Genes and Environment.2022;[Epub]     CrossRef
  • Continuous Vaginal Bleeding Induced By EGFR-TKI in Premenopausal Female Patients With EGFR Mutant NSCLC
    Min Yu, Xiaoyu Li, Xueqian Wu, Weiya Wang, Yanying Li, Yan Zhang, Shuang Zhang, Yongsheng Wang
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia
    Noni Novisari Soeroso, Fannie Rizki Ananda, Johan Samuel Sitanggang, Noverita Sprinse Vinolina
    F1000Research.2022; 11: 853.     CrossRef
  • Adverse Event Profiles of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Adenocarcinoma Lung Patients in North Sumatera Population
    Moh. Ramadhani Soeroso, Noni Novisari Soeroso, Setia Putra Tarigan, Elisna Syahruddin
    Open Access Macedonian Journal of Medical Sciences.2022; 10(T7): 134.     CrossRef
  • Landscape of EGFR mutations in lung adenocarcinoma: a single institute experience with comparison of PANAMutyper testing and targeted next-generation sequencing
    Jeonghyo Lee, Yeon Bi Han, Hyun Jung Kwon, Song Kook Lee, Hyojin Kim, Jin-Haeng Chung
    Journal of Pathology and Translational Medicine.2022; 56(5): 249.     CrossRef
  • Traditional Chinese Medicine Syndromes are Associated with Driver Gene Mutations and Clinical Characteristics in Patients with Lung Adenocarcinoma
    Jili Yang, Haiyan Lu, Niancai Jing, Bo Wang, Huanyu Guo, Shoukun Sun, Yue Zhang, Chan-Yen Kuo
    Evidence-Based Complementary and Alternative Medicine.2022; 2022: 1.     CrossRef
  • Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy
    Yoonjung Kim, Saeam Shin, Kyung-A Lee
    Cancer Cell International.2021;[Epub]     CrossRef
  • Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
    Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee
    Journal of Pathology and Translational Medicine.2021; 55(3): 181.     CrossRef
  • Osimertinib in Patients with T790M-Positive Advanced Non-small Cell Lung Cancer: Korean Subgroup Analysis from Phase II Studies
    Myung-Ju Ahn, Ji-Youn Han, Dong-Wan Kim, Byoung Chul Cho, Jin-Hyoung Kang, Sang-We Kim, James Chih-Hsin Yang, Tetsuya Mitsudomi, Jong Seok Lee
    Cancer Research and Treatment.2020; 52(1): 284.     CrossRef
  • Long non-coding RNA ATB promotes human non-small cell lung cancer proliferation and metastasis by suppressing miR-141-3p
    Guojie Lu, Yaosen Zhang, Klaus Roemer
    PLOS ONE.2020; 15(2): e0229118.     CrossRef
  • Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung
    Hyun Min Koh, Hyo Jung An, Gyung Hyuck Ko, Jeong Hee Lee, Jong Sil Lee, Dong Chul Kim, Jung Wook Yang, Min Hye Kim, Sung Hwan Kim, Kyung Nyeo Jeon, Gyeong-Won Lee, Se Min Jang, Dae Hyun Song
    Journal of Pathology and Translational Medicine.2019; 53(1): 13.     CrossRef
  • Epidermal growth factor receptor T790M mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Yongchun Zhou, Yuhui Ma, Hutao Shi, Yaxi Du, Yunchao Huang
    Scientific Reports.2018;[Epub]     CrossRef
  • Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
    Yong Won Choi, Jin-Hyuk Choi
    The Korean Journal of Internal Medicine.2017; 32(3): 422.     CrossRef
  • Molecular Testing of Lung Cancers
    Hyo Sup Shim, Yoon-La Choi, Lucia Kim, Sunhee Chang, Wan-Seop Kim, Mee Sook Roh, Tae-Jung Kim, Seung Yeon Ha, Jin-Haeng Chung, Se Jin Jang, Geon Kook Lee
    Journal of Pathology and Translational Medicine.2017; 51(3): 242.     CrossRef
  • MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values
    Geun Dong Lee, Seung Eun Lee, Doo-Yi Oh, Dan-bi Yu, Hae Min Jeong, Jooseok Kim, Sungyoul Hong, Hun Soon Jung, Ensel Oh, Ji-Young Song, Mi-Sook Lee, Mingi Kim, Kyungsoo Jung, Jhingook Kim, Young Kee Shin, Yoon-La Choi, Hyeong Ryul Kim
    Journal of Thoracic Oncology.2017; 12(8): 1233.     CrossRef
  • Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Yongchun Zhou, Yanlong Yang, Chenggang Yang, Yunlan Chen, Changshao Yang, Yaxi Du, Guangqiang Zhao, Yinjin Guo, Lianhua Ye, Yunchao Huang
    Oncotarget.2017; 8(9): 15023.     CrossRef
  • Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
    Seung Eun Lee, So-Young Lee, Hyung-Kyu Park, Seo-Young Oh, Hee-Joung Kim, Kye-Young Lee, Wan-Seop Kim
    Journal of Korean Medical Science.2016; 31(8): 1224.     CrossRef
  • MassARRAY, pyrosequencing, and PNA clamping for EGFR mutation detection in lung cancer tissue and cytological samples: a multicenter study
    Kyueng-Whan Min, Wan-Seop Kim, Se Jin Jang, Yoo Duk Choi, Sunhee Chang, Soon Hee Jung, Lucia Kim, Mee-Sook Roh, Choong Sik Lee, Jung Weon Shim, Mi Jin Kim, Geon Kook Lee
    Journal of Cancer Research and Clinical Oncology.2016; 142(10): 2209.     CrossRef
  • Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers
    Boram Lee, Taebum Lee, Se-Hoon Lee, Yoon-La Choi, Joungho Han
    Oncotarget.2016; 7(17): 23874.     CrossRef
Brief Case Report
Ovarian Remnant Syndrome at the Trochar Site: A Report of a Rare Complication Following Laparoscopic Ovarian Surgery
Ki Yong Na, Ji-Youn Sung, Kyu Yeoun Won, Gou Young Kim, Sung-Jig Lim, Suk-Hwan Lee
Korean J Pathol. 2013;47(3):304-306.   Published online June 25, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.3.304
  • 7,642 View
  • 53 Download
  • 4 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Síndrome de ovario remanente. Revisión bibliográfica. Evidencia actual
    M. Arnáez de la Cruz, J. Gallardo Martínez
    Clínica e Investigación en Ginecología y Obstetricia.2023; 50(4): 100902.     CrossRef
  • Clear cell carcinoma arising in an ovarian remnant 19 years after oophoerctomy: case report
    Ting-ting Yao, Shao-jie Zhao, Bing Zhang
    BMC Women's Health.2023;[Epub]     CrossRef
  • Clear-Cell Carcinoma Developing in Remnant Ovary After Hysterectomy and Bilateral Salpingo-Oophorectomy for Endometriosis
    Satoshi Ichigo, Hiroshi Takagi, Kazutoshi Matsunami, Takayuki Murase, Tsuneko Ikeda, Atsushi Imai
    Journal of Gynecologic Surgery.2014; 30(2): 114.     CrossRef
  • Malignant neoplasia arising from ovarian remnants following bilateral salpingo-oophorectomy (Review)
    ATSUSHI IMAI, KAZUTOSHI MATSUNAMI, HIROSHI TAKAGI, SATOSHI ICHIGO
    Oncology Letters.2014; 8(1): 3.     CrossRef
Case Study
Extrapelvic Uterus-like Masses Presenting as Colonic Submucosal Tumor: A Case Study and Review of Literature
Ki Yong Na, Gou Young Kim, Kyu Yeoun Won, Hyun-Soo Kim, Sang Won Kim, Chi Hoon Lee, Jae Myung Cha
Korean J Pathol. 2013;47(2):177-181.   Published online April 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.2.177
  • 7,802 View
  • 59 Download
  • 14 Crossref
AbstractAbstract PDF

A uterus-like mass (ULM) is a central cavity lined by endometrial glands and stroma and surrounded by thick-walled smooth muscles. To date, 31 cases of ULM have been reported in the English literature. ULM typically presents as a single mass and is located in the pelvic cavity. We report here a very rare case of multiple extrapelvic ULMs involving the cecum, descending colon, and mesocolon. After extensive literature research, our case appears to be the first case of multiple ULMs found in extrapelvic sites and the first case of ULM in the colon. The present case suggests that ULM should be included in the differential diagnosis of colonic submucosal tumors in female patients with chronic abdominal pain or menstruation-associated symptoms.

Citations

Citations to this article as recorded by  
  • Extrauterine adenomyoma: A case report and systematic review of the literature
    Matteo Giorgi, Luca Labanca, Gabriele Centini, Lucia Lazzeri, Francesco Giuseppe Martire, Ester Sorrentino, Virginia Mancini, Diego Raimondo, Antonio Raffone, Daniele Neola, Anna Chiara Aru, Nassir Habib, Paolo Casadio, Renato Seracchioli, Errico Zupi
    International Journal of Gynecology & Obstetrics.2024; 164(3): 869.     CrossRef
  • Extrapelvic “Uterus Like Mass” Following Laparoscopic Morcellation Hysterectomy - a Consequence of Iatrogenic Implantation?
    Neha Bakshi, Shashi Dhawan
    International Journal of Surgical Pathology.2023; 31(5): 791.     CrossRef
  • Extrauterine adenomyoma of the lesser omentum: A case report and review of the literature
    Yanlin Chen, Liangyong Deng, Jingbo Zhao, Tianwen Luo, Zhong Zuo
    Medicine.2022; 101(36): e30240.     CrossRef
  • Pelvic Pain and Adnexal Mass: Be Aware of Accessory and Cavitated Uterine Mass
    Pooya Iranpour, Sara Haseli, Pedram Keshavarz, Amirreza Dehghanian, Neda Khalili, Michael S. Firstenberg
    Case Reports in Medicine.2021; 2021: 1.     CrossRef
  • Endomyometriosis of the Rectum With Disseminated Peritoneal Leiomyomatosis 8 Years After Laparoscopic Myomectomy: A Case Report
    Giorgio La Greca, Cristina Colarossi, Paolo Di Mattia, Cecilia Gozzo, Marco De Zuanni, Eliana Piombino, Lorenzo Memeo
    Frontiers in Surgery.2021;[Epub]     CrossRef
  • Imaging Manifestations of Accessory Cavitated Uterine Mass—A Rare Mullerian Anomaly
    Tharani Putta, Reetu John, Betty Simon, Kirthi Sathyakumar, Anuradha Chandramohan, Anu Eapen
    Indian Journal of Radiology and Imaging.2021; 31(03): 545.     CrossRef
  • A rare case of ovarian adenomyoma mimicking primary invasive ovarian cancer with a contralateral serous borderline ovarian tumor: A case report and review of the literature
    Viola Liberale, Alessandra Surace, Lorenzo Daniele, Luca Liban Mariani
    Heliyon.2020; 6(7): e04406.     CrossRef
  • Extrauterine adenomyoma located in the inguinal region: a case report of a 44-year-old woman
    Winesh Ramphal, Chloé M L Peters, Luthy S M Alcalá, Dennis van Hamont, Paul D Gobardhan
    Journal of Surgical Case Reports.2020;[Epub]     CrossRef
  • Accessory and Cavitated Uterine Mass: Is It a Müllerian-Duct Anomaly?
    Vani Malhotra, Sonia Dahiya, Smiti Nanda, Meenakshi Chauhan, Vandana Bhuria
    Journal of Gynecologic Surgery.2020; 36(6): 350.     CrossRef
  • Uterus-like mass in the right broad ligament
    Lei Liu, Hui Yang, Shu-Peng Zhang
    Medicine.2019; 98(38): e17246.     CrossRef
  • Extrauterine adenomyoma: a review of the literature
    P.G. Paul, Gunjan Gulati, Hemant Shintre, Sumina Mannur, George Paul, Santwan Mehta
    European Journal of Obstetrics & Gynecology and Reproductive Biology.2018; 228: 130.     CrossRef
  • Uterus-like mass
    Jian He, Jie Xu, Hong-Yan Zhou
    Medicine.2016; 95(39): e4961.     CrossRef
  • Endometrioid Adenocarcinoma in an Extrauterine Adenomyoma
    Michael A. Ulm, David B. Robins, Edwin M. Thorpe, Mark E. Reed
    Obstetrics & Gynecology.2014; 124(2): 445.     CrossRef
  • Endomyometriosis (“Uterus - like mass”) in an XY Male
    Raul S. González, Cindy L. Vnencak-Jones, Chanjuan Shi, Oluwole Fadare
    International Journal of Surgical Pathology.2014; 22(5): 421.     CrossRef
Case Reports
Angiomyomatous Hamartoma of Popliteal Lymph Nodes Occurring in Association with Diffuse Pigmented Villonodular Synovitis of Knee.
Hyun Soo Kim, Ki Yong Na, Jae Hoon Lee, Nam Su Cho, Gou Young Kim, Sung Jig Lim
Korean J Pathol. 2011;45:S58-S61.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.S1.S58
  • 3,031 View
  • 19 Download
AbstractAbstract PDF
We report the first case of an angiomyomatous hamartoma (AH) of the popliteal lymph nodes (LNs) occurring in association with diffuse pigmented villonodular synovitis (PVNS) of the knee. AH is a rare benign vascular disease with a predisposition for the LNs of the inguinal region. Twenty-five cases of AH have been reported to date; however, the precise pathogenesis is still undetermined. In the present case, an open synovectomy revealed two of three popliteal LNs in close proximity to the extra-articular component of diffuse PVNS. These LNs demonstrated irregularly distributed thick-walled blood vessels in the hilum. These vessels extended into the medulla and cortex and were associated with haphazardly arranged smooth muscle cells in the sclerotic stroma. These findings are compatible with an AH. Our observations raise the possibility that AH of the popliteal LNs may represent an abnormal proliferative reaction against the inflammatory process caused by PVNS of the knee.
Ectopic Epididymis in Testicular Appendices: Report of Two Cases.
Hyun Soo Kim, Gou Young Kim, Hyung Lae Lee, Youn Wha Kim, Sung Jig Lim
Korean J Pathol. 2011;45:S11-S14.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.S1.S11
  • 2,714 View
  • 20 Download
AbstractAbstract PDF
We report two cases of ectopic epididymal ducts and efferent ductules in the testicular appendices (TAs) of adult men with normally descended testes. In both cases, a sessile TA was incidentally found at the upper pole of the right testis during the scrotal hydrocelectomy. Microscopically, a few closely arranged tubules were detected within the TA. In the first case, the tubules were lined with a pseudostratified columnar epithelium with numerous, long microvilli, and were surrounded by a smooth muscle coat. In contrast, in the second case, the tubules had a wavy luminal surface, because ciliated columnar cells alternated with groups of cuboidal cells. In both cases, strong CD10 immunoreactivity was observed in the luminal border of the lining epithelium. Surgical pathologists should be aware of the presence of both ectopic epididymal ducts and efferent ductules that can occur in TAs, in order to avoid misinterpretation as transected, functional reproductive structures.
Original Articles
Uncoupling Protein 2 (UCP2) and p53 Expression in Invasive Ductal Carcinoma of Breast.
Kyu Yeoun Won, Gou Young Kim, Youn Wha Kim, Sung Jig Lim, Jeong Yoon Song
Korean J Pathol. 2010;44(6):565-570.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.6.565
  • 3,913 View
  • 26 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Uncoupling protein 2 (UCP2) is a recently identified mitochondrial inner membrane anion carrier and a negative regulator of reactive oxygen species production. In this study, we evaluated the characteristics and relationships of UCP2 and p53 expression in breast cancer tissues.
METHODS
Tissue microarray slides from 107 cases of invasive ductal carcinoma of the breast were constructed, UCP2 and p53 immunohistochemical staining was conducted, and clinicopathological correlations were investigated.
RESULTS
UCP2 expression in invasive ductal carcinoma was high in 53 cases (49.5%), while p53 expression in invasive ductal carcinoma was high in 37 cases (34.6%). UCP2 expression was correlated significantly with histological grade (p = 0.038) and mitotic count (p = 0.050). UCP2 expression was correlated significantly with p53 expression in invasive ductal carcinoma of the breast (p = 0.045). UCP2 expression (p = 0.8308) and p53 expression (p = 0.3292) showed no significant difference for the overall survival rate in patients with invasive ductal carcinoma.
CONCLUSIONS
UCP2 expression in invasive ductal carcinoma increased proportionally with histological grade and mitotic count. High UCP2 expression in invasive ductal carcinoma was observed in conjunction with high p53 expression.

Citations

Citations to this article as recorded by  
  • Forkhead box protein A1 inhibits the expression of uncoupling protein 2 in hydrogen peroxide-induced A549 cell line
    Lan Song, Zhaojun Xu, Ling Li, Mei Hu, Lijuan Cheng, Lingli Chen, Bo Zhang
    Cell Stress and Chaperones.2014; 19(1): 53.     CrossRef
  • New Aspects of Mitochondrial Uncoupling Proteins (UCPs) and Their Roles in Tumorigenesis
    Delira Robbins, Yunfeng Zhao
    International Journal of Molecular Sciences.2011; 12(8): 5285.     CrossRef
Clinicopathological Significance of Invasive Ductal Carcinoma with High Prevalence of CD44(+)/CD24(-/low) Tumor Cells in Breast Cancer.
Ji Youn Sung, Gou Young Kim, Yong Koo Park, Juhie Lee, Youn Wha Kim, Sung Jig Lim
Korean J Pathol. 2010;44(4):390-396.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.4.390
  • 3,459 View
  • 22 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Epithelial tumor cells with a CD44(+)/CD24(-/low) immunoprofile may have the ability to cause breast cancer. We studied these cells and their clinicopathological significance.
METHODS
The clinicopathologic findings of 100 invasive ductal carcinoma (IDC) cases and 45 ductal carcinoma in situ (DCIS) cases were reviewed. CD44(+)/CD24(-/low) tumor cells were identified by immunohistochemistry, and their clinicopathological implications in IDC and DCIS were analyzed.
RESULTS
IDC with a high prevalence of CD44(+)/CD24(-/low) tumor cells was significantly associated with larger mass, higher grade, estrogen receptor (ER) negativity, and tumor cells with a higher frequency of metastasis. The proportion of CD44(+)/CD24(-/low) tumor cells in IDC, and its DCIS components was not significantly different, whereas the proportion of CD44(+)/CD24(-/low) tumor cells was higher in DCIS than in the DCIS component of IDC (p < 0.001).
CONCLUSIONS
IDC with a high prevalence of CD44(+)/CD24(-/low) tumor cells might correlate with aggressive features, such as ER and higher grades. Moreover, the proportion of CD44(+)/CD24(-/low) tumor cells in the DCIS components of IDC and DCIS might harbor different biology, which may lead to differences in cancer progression and early carcinogenesis.

Citations

Citations to this article as recorded by  
  • Clinicopathologic Characteristics of Breast Cancer Stem Cells Identified on the Basis of Aldehyde Dehydrogenase 1 Expression
    Yoon Seok Kim, Min Jung Jung, Dong Won Ryu, Chung Han Lee
    Journal of Breast Cancer.2014; 17(2): 121.     CrossRef
  • CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy
    Agnieszka Adamczyk, Joanna A. Niemiec, Aleksandra Ambicka, Anna Mucha-Małecka, Jerzy Mituś, Janusz Ryś
    Journal of Molecular Histology.2014; 45(1): 35.     CrossRef
Expression of Raf-1 Kinase Inhibitory Protein in Extrahepatic Bile Duct Carcinoma.
Hyun Soo Kim, Gou Young Kim, Sung Jig Lim, Youn Wha Kim
Korean J Pathol. 2010;44(3):234-242.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.3.234
  • 3,506 View
  • 19 Download
  • 6 Crossref
AbstractAbstract PDF
BACKGROUND
Raf-1 kinase inhibitory protein (RKIP) recently has been identified as a metastasis suppressor in a variety of human carcinomas. The prognostic significance of RKIP expression in extrahepatic bile duct (EBD) carcinoma has not been studied. The aims of the current study were to evaluate RKIP expression and to determine the prognostic significance of RKIP expression in EBD carcinoma.
METHODS
Immunohistochemical staining for RKIP was performed for 131 cases of EBD carcinoma. The associations of RKIP expression with clinicopathologic parameters and patient outcomes were examined. Multivariate logistic regression analysis was used to identify independent predictive parameters for lymphovascular invasion and nodal and distant metastases.
RESULTS
Loss of RKIP expression was observed in 55.0% (72/131) of cases. EBD carcinoma had significantly lower RKIP immunoreactivity than normal EBD (p < 0.001). Loss of RKIP expression was significantly associated with lymphatic invasion (p = 0.030) and nodal metastasis (p = 0.036), but it was not found to be a significant prognostic predictor for overall, disease-free or distant metastasis-free survival. In addition, loss of RKIP expression was an independent predictor for lymphatic invasion (p = 0.027).
CONCLUSIONS
These results suggest that RKIP may play a role in the suppression of lymphatic invasion and nodal metastasis in EBD carcinoma.

Citations

Citations to this article as recorded by  
  • Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma
    Hyun-Soo Kim, Gun Yoon, Sung-Im Do, Sung-Joo Kim, Youn-Wha Kim
    Oncotarget.2016; 7(12): 15187.     CrossRef
  • Expression of phosphorylated extracellular signal-regulated kinase at the invasive front of hepatic colorectal metastasis
    HYUN-SOO KIM, SUNG-IM DO, BYEONG-JOO NOH, YOUNG IN JEONG, SUN JIN PARK, YOUN WHA KIM
    Oncology Letters.2015; 9(3): 1261.     CrossRef
  • Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma
    Hyun-Soo Kim, Kyu Yeoun Won, Gou Young Kim, Soo Cheol Kim, Yong-Koo Park, Youn Wha Kim
    Pathology - Research and Practice.2012; 208(5): 292.     CrossRef
  • Expression of Raf-1 kinase inhibitory protein in carcinoma of the ampulla of Vater
    Hyun-Soo Kim, Sun Ho Lee, Kyu Yeoun Won, Gou Young Kim, Yong-Koo Park, Youn Wha Kim
    Virchows Archiv.2012; 460(1): 61.     CrossRef
  • Raf-1 Kinase Inhibitory Protein Expression in Thyroid Carcinomas
    Hyun-Soo Kim, Gou Young Kim, Sung-Jig Lim, Youn Wha Kim
    Endocrine Pathology.2010; 21(4): 253.     CrossRef
  • Loss of Raf-1 kinase inhibitory protein in pancreatic ductal adenocarcinoma
    Hyun-Soo Kim, Gou Young Kim, Sung-Jig Lim, Youn Wha Kim
    Pathology.2010; 42(7): 655.     CrossRef
Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision-Like Protein HuR in Gallbladder Carcinoma.
Sung Im Do, Gou Young Kim, Sung Jig Lim, Youn Wha Kim
Korean J Pathol. 2010;44(1):42-47.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.1.42
  • 3,029 View
  • 17 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Cyclooxygenase-2 (COX-2) is an enzyme that promotes proliferation of tumor cells. HuR is a member of the family of embryonic lethal abnormal vision-like proteins. Recent studies show that cytoplasmic HuR stabilizes the mRNA of COX-2 and regulates the expression of COX-2. Moreover, cytoplasmic HuR expression is associated with a poorer prognosis for patients with some cancers. The aim of this study was to investigate the expression patterns of and the relationship between COX-2 and HuR in gallbladder carcinoma.
METHODS
We analyzed COX-2 and HuR expression by immunohistochemical staining of 108 gallbladder carcinomas.
RESULTS
COX-2 expression and nuclear and cytoplasmic HuR expression were seen in, respectively, 61 (56.5%), 77 (71.3%), and 4 (3.7%) cases. COX-2 and nuclear HuR were simultaneously expressed in 44 of the 108 samples without any quantitative association between the levels of each. COX-2 expression correlated with tumor stage, differentiation (based on histology), lymph node metastasis, perineural invasion, and survival. Nuclear and cytological expression of HuR did not correlate with any clinical parameters.
CONCLUSIONS
COX-2 expression but not HuR may play an important role in the prognosis of patients with gallbladder carcinoma.

Citations

Citations to this article as recorded by  
  • Prognostic molecular markers in resected extrahepatic biliary tract cancers; a systematic review and meta-analysis of immunohistochemically detected biomarkers
    Robert P Jones, Nicholas TE Bird, Richard A Smith, Daniel H Palmer, Steven W Fenwick, Graeme J Poston, Hassan Z Malik
    Biomarkers in Medicine.2015; 9(8): 763.     CrossRef
Case Reports
Smooth Muscle Hyperplasia of the Epididymis: Report of A Case and Review of the Literature.
Hyun Soo Kim, Ji Youn Sung, Gou Young Kim, Sung Jig Lim, Hyun Cheol Kim, Hyung Lae Lee
Korean J Pathol. 2009;43(2):177-181.
DOI: https://doi.org/10.4132/KoreanJPathol.2009.43.2.177
  • 3,145 View
  • 20 Download
  • 4 Crossref
AbstractAbstract PDF
A 66-year-old man underwent surgery to remove an incidentally discovered non-tender intrascrotal mass. Ultrasonography revealed an irregular-margined, heterogeneous mass-like lesion in the epididymal tail. The mass was relatively well circumscribed but unencapsulated, irregular and firm; it consisted of expansile, increased smooth muscle fascicles originating from the epididymal muscular coat. Its cellular growth pattern lacked the cohesive, well-circumscribed proliferation pattern typical of a leiomyoma. A diagnosis of smooth muscle hyperplasia of the epididymis was made. Although ultrasonography is the imaging modality of choice for evaluating suspected intrascrotal masses, there are times when it cannot reliably identify the character of the masses and distinguish malignant from benign lesions. Ill-defined, solid extratesticular masses, that are ultrasonographically ambiguous, should be excised and confirmed histopathologically and smooth muscle hyperplasia of the epididymis should be included in the differential diagnosis of solid extratesticular masses.

Citations

Citations to this article as recorded by  
  • Smooth muscle hyperplasia of the testicular adnexa: a clinicopathologic study of 12 cases
    Fatimah Alruwaii, David J. Grignon, Muhammad T. Idrees
    Human Pathology.2020; 99: 27.     CrossRef
  • Hiperplasia muscular paratesticular (epididimaria) pseudotumoral. Descripción de 2 casos
    Inmaculada Ruiz Molina, Vicente Cívico Amat, Beatriz Santiago Agredano
    Medicina Clínica.2019; 152(5): e25.     CrossRef
  • Pseudotumoral paratesticular (epididymal) muscle hyperplasia. Two case reports
    InmaculadaRuiz Ruiz Molina, Vicente Cívico Amat, Beatriz Santiago Agredano
    Medicina Clínica (English Edition).2019; 152(5): e25.     CrossRef
  • Smooth muscle hyperplasia of the epididymis
    O Blach, AM Pollock, D Douglas
    Journal of Surgical Case Reports.2011; 2011(10): 10.     CrossRef
Inflammatory Myofibroblastic Tumor of the Mesentery: A case report.
Sung Jig Lim, Gou Young Kim, Jae Hoon Park, Youn Wha Kim, Yong Koo Park, Ju Hie Lee, Moon Ho Yang
Korean J Pathol. 1999;33(9):729-732.
  • 1,648 View
  • 22 Download
AbstractAbstract PDF
Inflammatory myofibroblastic tumor or inflammatory pseudotumor is characterized by spindle cell proliferation with inflammatory cell infiltration, predominantly plasma cells and lymphocytes. We have experienced a case of inflammatory myofibroblastic tumor of the mesentery in a 57-year-old male patient with intermittent abdominal pain. On computer tomography, a well demarcated mass was seen in the mesenteric side of the ascending colon. Right hemicolectomy was performed under the impression of the metastatic tumor of lymph nodes. Grossly, a rather well-circumscribed gray white mass was noted in the mesentery of the ascending colon. Microscopically, the lesion consisted of plump spindle cells and accompanying inflammatory cellular infiltrates. The spindle cells were positive for vimentin.
Pulmonary Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia associated with Tuberous Sclerosis: A Case Report.
Gou Young Kim, Juhie Lee, Yong Koo Park, Youn Wha Kim, Jae Hoon Park, Moon Ho Yang
Korean J Pathol. 2002;36(1):51-54.
  • 1,649 View
  • 15 Download
AbstractAbstract PDF
Lymphangioleiomyomatosis (LAM) is characterized by a hamartomatous proliferation of smooth muscle cells in the lung, mediastium, and abdomen. In the lung, an abnormal proliferation of smooth muscle is seen along the airways, blood vessels, and lymphatics, resulting in honeycombing of the lung. It occurs in 0.1-1% of tuberous sclerosis (TSC) patients. Micronodular pneumocyte hyperplasia (MNPH) is a rare but distinctive pulmonary manifestation of TSC, and appears to be a hamartomatous proliferation of the type II pneumocytes. We report a case of pulmonary LAM and MNPH associated with TSC and bilateral renal angiomyolipoma in a 26-year-old woman. Immunohistochemically, the spindle cells of LAM were positive for HMB-45, but the type II pneumocytes of MNPH were negative.
Original Article
Immunoexpressions of Thyroid Transcription Factor-1 and bcl-2 in Congenital Cystic Adenomatoid Malformation.
Na Rae Kim, Dong Hoon Kim, Gou Young Kim, Dae Shick Kim, Joungho Han
Korean J Pathol. 2003;37(1):10-14.
  • 1,510 View
  • 11 Download
AbstractAbstract PDF
BACKGROUND
Congenital cystic adenomatoid malformation (CCAM) is a congenital abnormality of branching morphogenesis of the lung. Thyroid transcription factor-1 (TTF-1) is detected in human respiratory epithelial cells from 11 weeks of gestation, and at full term, TTF-1 expression is confined within type II epithelial cells and in some respiratory nonciliated bronchiolar epithelial cells. Immunoexpression of bcl-2 is intimately related to apoptosis during the development.
METHODS
To elucidate the nature of the lesion, TTF-1 expression was evaluated in twenty-four cases of CCAM (eight cases of type 1 and sixteen cases of type 2) along with immunostaining for bcl-2. For the control group, four cases of fetal lungs (19 week-, 21 week-, 27 week- and 40 week-gestational age) were also evaluated. In all cases of CCAM, TTF-1 was detected in the nuclei of epithelial cells lining the cysts.
RESULTS
TTF-1 was expressed in the majority of the bronchiolar-like epithelial cells of the cysts in CCAM types 1, and 2, where almost 100% of the lining cells of the cysts were TTF-1 positive with variable intensity, while negative TTF-1 expressions were found in the alveolar-like epithelium of the adjacent alveoli or distal nonciliated bronchi. For bcl-2 immunostaining, no lining epithelial cells of the cysts were stained except for the infiltrating lymphocytes. In the control group, strong immunoreactivities found in early fetal stages were absent in the full-term aged lung (40 gestational weeks).
CONCLUSION
These results support the hypothesis that CCAM types 1 and 2 reflect the abnormalities in lung morphogenesis and differentiation that are distinct from those for normally developed alveolar epithelium or adjacent bronchial epithelium, thus retaining the abnormal TTF-1 immunoreactions. Though restricted to CCAM types 1 and 2 in this study, CCAM might be related to TTF-1 rather than apoptosis in the morphogenesis of the developing lung.

J Pathol Transl Med : Journal of Pathology and Translational Medicine